Literature DB >> 17346213

Human defensins: turning defense into offense?

Erik de Leeuw1, Wuyuan Lu.   

Abstract

Defensins are a family of antimicrobial cationic peptides that act as a rapid response force against microbial invasion in a wide range of organisms, including plants, insects, animals and humans. In humans, defensins are produced predominantly by leukocytes and epithelial cells and are an important factor of innate immunity. In addition to their major role as natural antibiotics, defensins are increasingly recognized as signaling molecules in adaptive immunity and aberrant defensin expression has been associated with infectious diseases. In this review, we discuss the role of human defensins in relation to infectious disease and the possibility of novel defensin-based therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346213     DOI: 10.2174/187152607780090702

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  6 in total

1.  Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II.

Authors:  Erik de Leeuw; Changqing Li; Pengyun Zeng; Chong Li; Marlies Diepeveen-de Buin; Wei-Yue Lu; Eefjan Breukink; Wuyuan Lu
Journal:  FEBS Lett       Date:  2010-03-07       Impact factor: 4.124

2.  Predictions suggesting a participation of beta-sheet configuration in the M2 domain of the P2X(7) receptor: a novel conformation?

Authors:  Pedro Celso Nogueira Teixeira; Cristina Alves Magalhães de Souza; Mônica Santos de Freitas; Débora Foguel; Ernesto Raul Caffarena; Luiz Anastacio Alves
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

3.  In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid.

Authors:  Ling C Huang; Rachel L Redfern; Srihari Narayanan; Rose Y Reins; Alison M McDermott
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

4.  Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins.

Authors:  Robert I Lehrer; Grace Jung; Piotr Ruchala; Wei Wang; Ewa D Micewicz; Alan J Waring; Eugene J Gillespie; Kenneth A Bradley; Adam J Ratner; Richard F Rest; Wuyuan Lu
Journal:  Infect Immun       Date:  2009-07-06       Impact factor: 3.441

5.  Human β-Defensin 2 in Primary Sclerosing Cholangitis.

Authors:  Cindy Chang; Ana Lleo; Anchasa Kananurak; Fabio Grizzi; Koichi Tsuneyama; Pietro Invernizzi; Charles L Bevins; Christopher L Bowlus
Journal:  Clin Transl Gastroenterol       Date:  2017-03-16       Impact factor: 4.488

6.  Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate.

Authors:  Sara Dabirian; Yasaman Taslimi; Farnaz Zahedifard; Elham Gholami; Fatemeh Doustdari; Mahdieh Motamedirad; Shohreh Khatami; Kayhan Azadmanesh; Susanne Nylen; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.